, Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies, Lancet HIV, vol.4, issue.8, pp.349-56, 2017.

, Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies, Lancet Lond Engl, vol.372, issue.9635, pp.293-302, 2008.

G. Guaraldi, G. Orlando, S. Zona, M. Menozzi, F. Carli et al., Premature age-related comorbidities among HIV-infected persons compared with the general population, Clin Infect Dis Off Publ Infect Dis Soc Am, 2011.

J. Schouten, F. W. Wit, I. G. Stolte, N. A. Kootstra, M. Van-der-valk et al., Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.59, issue.12, pp.1787-97, 2014.

J. N. Dock and R. B. Effros, Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence, Aging Dis, vol.2, issue.5, pp.382-97, 2011.

J. Cohen and C. Torres, HIV-associated cellular senescence: A contributor to accelerated aging, Ageing Res Rev, vol.36, pp.117-141, 2017.

J. B. Margolick, J. H. Bream, O. Martínez-maza, J. Lopez, X. Li et al., Frailty and Circulating Markers of Inflammation in HIV+ and HIV? Men in the Multicenter AIDS Cohort Study, JAIDS J Acquir Immune Defic Syndr, vol.74, issue.4, pp.407-424, 2017.

S. G. Deeks, S. R. Lewin, and D. V. Havlir, The End of AIDS: HIV Infection as a Chronic Disease, Lancet, vol.382, issue.9903, pp.1525-1558, 2013.

P. Patel, C. E. Rose, P. Y. Collins, B. Nuche-berenguer, V. V. Sahasrabuddhe et al., Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis, AIDS Lond Engl, vol.32, issue.1, pp.5-20, 2018.

P. Patel, K. Sabin, and P. Godfrey-faussett, Approaches to Improve the Surveillance, Monitoring, and Management of Noncommunicable Diseases in HIV-Infected Persons: Viewpoint. JMIR Public Health Surveill, vol.4, p.10989, 2018.

L. Desquilbet, L. P. Jacobson, L. P. Fried, J. P. Phair, B. D. Jamieson et al., HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty, J Gerontol A Biol Sci Med Sci, vol.62, issue.11, pp.1279-86, 2007.

L. P. Fried, C. M. Tangen, J. Walston, A. B. Newman, C. Hirsch et al., Frailty in older adults: evidence for a phenotype, J Gerontol A Biol Sci Med Sci, vol.56, issue.3, pp.146-156, 2001.

C. Cazanave, M. Dupon, V. Lavignolle-aurillac, N. Barthe, S. Lawson-ayayi et al., Reduced bone mineral density in HIV-infected patients: prevalence and associated factors, AIDS Lond Engl, vol.22, issue.3, pp.395-402, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00186715

L. Richert, P. Dehail, P. Mercié, F. Dauchy, M. Bruyand et al., High frequency of poor locomotor performance in HIV-infected patients, AIDS Lond Engl, vol.25, issue.6, pp.797-805, 2011.

C. Dufouil, B. Dubois, B. Vellas, F. Pasquier, F. Blanc et al., Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort, Alzheimers Res Ther, vol.9, issue.1, p.67, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01981009

F. Bonnet, H. Amieva, F. Marquant, C. Bernard, M. Bruyand et al., Cognitive disorders in HIV-infected patients: are they HIV-related?, AIDS Lond Engl, vol.27, issue.3, pp.391-400, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01101101

F. Sofi, C. Macchi, R. Abbate, G. F. Gensini, and A. Casini, Mediterranean diet and health status: an updated meta-analysis and a proposal for a literature-based adherence score. Public Health Nutr, vol.17, pp.2769-82, 2014.

E. J. Wing and . Hiv, Int J Infect Dis IJID Off Publ Int Soc Infect Dis, vol.53, pp.61-69, 2016.

P. Mcgettrick, E. A. Barco, and P. Mallon, Ageing with HIV. Healthc Basel Switz, vol.6, 2018.

M. Thurn and D. R. Gustafson, Faces of Frailty in Aging with HIV Infection, Curr HIV/AIDS Rep, vol.14, issue.1, pp.31-38, 2017.

K. M. Erlandson, A. A. Allshouse, C. M. Jankowski, S. Mawhinney, W. M. Kohrt et al., Functional impairment is associated with low bone and muscle mass among persons aging with HIV infection, J Acquir Immune Defic Syndr, vol.63, issue.2, pp.209-224, 1999.

K. M. Erlandson, A. A. Allshouse, C. M. Jankowski, S. Duong, S. Mawhinney et al., Comparison of functional status instruments in HIV-infected adults on effective antiretroviral therapy, HIV Clin Trials, vol.13, issue.6, pp.324-358, 2012.

M. Greene, K. E. Covinsky, V. Valcour, Y. Miao, J. Madamba et al., Geriatric Syndromes in Older HIV-Infected Adults, J Acquir Immune Defic Syndr, vol.69, issue.2, pp.161-168, 1999.

M. Greene, K. Covinsky, J. Astemborski, D. A. Piggott, T. Brown et al., The relationship of physical performance with HIV disease and mortality, AIDS Lond Engl, vol.28, issue.18, pp.2711-2720, 2014.

C. A. Sabin and P. Reiss, Epidemiology of ageing with HIV: what can we learn from cohorts? AIDS Lond Engl, vol.31, pp.121-129, 201701.

T. Engel, M. Raffenberg, C. Marzolini, M. Cavassini, H. Kovari et al., HIV and Aging -Perhaps Not as Dramatic as We Feared?, Gerontology, vol.64, issue.5, pp.446-56, 2018.

M. J. Bolland, T. Wang, A. Grey, G. D. Gamble, and I. R. Reid, Stable bone density in HAART-treated individuals with HIV: a meta-analysis, J Clin Endocrinol Metab, vol.96, issue.9, pp.2721-2752, 2011.

M. J. Bolland, A. Grey, A. M. Horne, S. E. Briggs, M. G. Thomas et al., Stable bone mineral density over 6 years in HIV-infected men treated with highly active antiretroviral therapy (HAART), Clin Endocrinol, p.2012

S. S. Han, K. W. Kim, K. Kim, K. Y. Na, C. Kim et al., Lean mass index: a better predictor of mortality than body mass index in elderly Asians, J Am Geriatr Soc, vol.58, issue.2, pp.312-319, 2010.

S. Safrin and C. Grunfeld, Fat distribution and metabolic changes in patients with HIV infection, AIDS Lond Engl, 1999.

Á. H. Borges, J. Hoy, E. Florence, D. Sedlacek, H. Stellbrink et al., Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort, vol.64, pp.1413-1434, 2017.

K. M. Erlandson, J. E. Lake, M. Sim, J. Falutz, C. M. Prado et al., Bone Mineral Density Declines Twice as Quickly Among HIV-Infected Women Compared With Men, J Acquir Immune Defic Syndr, vol.77, issue.3, pp.288-94, 1999.

L. Richert, M. Brault, P. Mercié, F. Dauchy, M. Bruyand et al., Decline in locomotor functions over time in HIV-infected patients, AIDS Lond Engl, vol.28, issue.10, pp.1441-1450, 2014.

K. Alford, S. Banerjee, E. Nixon, C. O'brien, O. Pounds et al., Assessment and Management of HIV-Associated Cognitive Impairment: Experience from a Multidisciplinary Memory Service for People Living with HIV, Brain Sci, vol.9, issue.2, 2019.

V. Ianas, E. Berg, M. J. Mohler, C. Wendel, and S. A. Klotz, Antiretroviral therapy protects against frailty in HIV-1 infection

, J Int Assoc Provid AIDS Care, vol.12, issue.1, pp.62-68, 2013.

M. De-lorgeril, Mediterranean diet and cardiovascular disease: historical perspective and latest evidence, Curr Atheroscler Rep, vol.15, issue.12, p.370, 2013.

J. E. Michalek, H. G. Preuss, H. A. Croft, P. L. Keith, S. C. Keith et al., Changes in total body bone mineral density following a common bone health plan with two versions of a unique bone health supplement: a comparative effectiveness research study, Nutr J, vol.10, p.32, 2011.

H. Wengreen, R. G. Munger, A. Cutler, A. Quach, A. Bowles et al., Prospective study of Dietary Approaches to Stop Hypertension-and Mediterranean-style dietary patterns and age-related cognitive change: the Cache County Study on Memory, Health and Aging, Am J Clin Nutr, vol.98, issue.5, pp.1263-71, 2013.

F. R. Sattler, N. Rajicic, K. Mulligan, K. E. Yarasheski, S. L. Koletar et al., Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial, Am J Clin Nutr, vol.88, issue.5, pp.1313-1334, 2008.

C. B. Harley, W. Liu, M. Blasco, E. Vera, W. H. Andrews et al., A natural product telomerase activator as part of a health maintenance program, Rejuvenation Res, vol.14, issue.1, pp.45-56, 2011.

A. M. Tang, T. Quick, M. Chung, and C. A. Wanke, Nutrition assessment, counseling, and support interventions to improve health-related outcomes in people living with HIV/AIDS: a systematic review of the literature, J Acquir Immune Defic Syndr, vol.68, issue.3, pp.340-349, 1999.

, Recommended Treatment Strategies for Clinicians Managing Older Patients with HIV

, Bibliographie de l'introduction 1. Diagnoses of HIV infection among adults aged 50 years and older in the United States and dependent areas, p.118, 2011.

, HIV Among People Aged 50 and Over | Age | HIV by Group | HIV/AIDS | CDC, HIV/AIDS surveillance in Europe -WHO 2017, 2018.

, HIV/AIDS (UNAIDS) UNP on. HIV and Aging: A special supplement to the UNAIDS report on the global AIDS epidemic, 2013.

F. Santé-publique, VIH/sida -Données épidémiologique, 2018.

V. Le and F. Sida-en, , 2018.

M. Smit, K. Brinkman, S. Geerlings, C. Smit, K. Thyagarajan et al., Future challenges for clinical care of an ageing population infected with HIV: a modelling study, Lancet Infect Dis, vol.15, issue.7, pp.810-818, 2015.

A. Gueler, A. Moser, A. Calmy, H. F. Günthard, E. Bernasconi et al., Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population, AIDS Lond Engl, vol.31, issue.3, pp.427-463, 2017.

, Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies, Lancet HIV, vol.4, issue.8, pp.349-56, 2017.

A. Mocroft, R. Brettle, O. Kirk, A. Blaxhult, J. M. Parkin et al., Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study, AIDS Lond Engl, vol.16, issue.12, pp.1663-71, 2002.

C. J. Smith, L. Ryom, R. Weber, P. Morlat, C. Pradier et al., Trends in underlying causes of death in people with HIV from, vol.384, pp.241-249, 1999.

P. Morlat, C. Roussillon, S. Henard, D. Salmon, F. Bonnet et al., Causes of death among HIV-infected patients in France in 2010 (national survey): trends since, AIDS Lond Engl, vol.28, issue.8, pp.1181-91, 2000.

N. Obel, L. H. Omland, G. Kronborg, C. S. Larsen, C. Pedersen et al., Impact of Non-HIV and HIV Risk Factors on Survival in HIV-Infected Patients on HAART: A Population-Based Nationwide Cohort Study, PLoS ONE, vol.6, issue.7, 2011.

R. Martin-iguacel, J. M. Llibre, and N. Friis-moller, Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now? Curr HIV/AIDS Rep, vol.12, pp.375-87, 2015.

M. J. Feinstein, E. Bahiru, C. Achenbach, C. T. Longenecker, P. Hsue et al., Patterns of Cardiovascular Mortality for HIV-Infected Adults in the United States: 1999 to 2013, Am J Cardiol, vol.117, issue.2, pp.214-234, 2016.

F. J. Palella, R. K. Baker, A. C. Moorman, J. S. Chmiel, K. C. Wood et al., Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study, J Acquir Immune Defic Syndr, vol.43, issue.1, pp.27-34, 1999.

F. Bonnet, G. Chêne, R. Thiébaut, M. Dupon, S. Lawson-ayayi et al., Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, HIV Med, vol.8, issue.8, pp.547-54, 2000.

G. Guaraldi, G. Orlando, S. Zona, M. Menozzi, F. Carli et al., Premature age-related comorbidities among HIV-infected persons compared with the general population, Clin Infect Dis Off Publ Infect Dis Soc Am, 2011.

S. G. Deeks, HIV infection, inflammation, immunosenescence, and aging, Annu Rev Med, vol.62, pp.141-55, 2011.

L. P. Fried, C. M. Tangen, J. Walston, A. B. Newman, C. Hirsch et al., Frailty in older adults: evidence for a phenotype, J Gerontol A Biol Sci Med Sci, vol.56, issue.3, pp.146-156, 2001.

A. Clegg, J. Young, S. Iliffe, M. O. Rikkert, and K. Rockwood, Frailty in elderly people, Lancet Lond Engl, vol.381, issue.9868, pp.752-62, 2013.

K. W. Kooij, F. Wit, J. Schouten, M. Van-der-valk, M. H. Godfried et al., HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls, AIDS Lond Engl, vol.30, issue.2, pp.241-50, 2016.

M. Greene, K. E. Covinsky, V. Valcour, Y. Miao, J. Madamba et al., Geriatric Syndromes in Older HIV-Infected Adults, J Acquir Immune Defic Syndr, vol.69, issue.2, pp.161-168, 1999.

N. F. Önen and E. T. Overton, A review of premature frailty in HIV-infected persons; another manifestation of HIV-related accelerated aging, Curr Aging Sci, vol.4, issue.1, pp.33-41, 2011.

M. D. John, M. Greene, N. A. Hessol, R. Zepf, A. H. Parrott et al., Geriatric Assessments and Association With VACS Index Among HIV-Infected Older Adults in San Francisco, J Acquir Immune Defic Syndr, vol.72, issue.5, pp.534-575, 1999.

J. A. Ávila-funes, P. F. Belaunzarán-zamudio, O. Tamez-rivera, B. Crabtree-ramírez, A. P. Navarrete-reyes et al., Correlates of Prevalent Disability Among HIV-Infected Elderly Patients, AIDS Res Hum Retroviruses, vol.32, issue.2, pp.155-62, 2016.

L. Desquilbet, J. B. Margolick, L. P. Fried, J. P. Phair, B. D. Jamieson et al., Relationship between a frailtyrelated phenotype and progressive deterioration of the immune system in HIV-infected men, J Acquir Immune Defic Syndr, vol.50, issue.3, pp.299-306, 1999.

A. L. Willig, E. T. Overton, and M. S. Saag, The Silent Epidemic -Frailty and Aging with HIV. Total Patient Care HIV HCV, vol.1, pp.6-17, 2016.

J. P. Tate, A. C. Justice, M. D. Hughes, F. Bonnet, P. Reiss et al., An internationally generalizable risk index for mortality after one year of antiretroviral therapy, AIDS Lond Engl, vol.27, issue.4, pp.563-72, 2013.

G. V. Escota, P. Patel, J. T. Brooks, T. Bush, L. Conley et al., Short communication: The Veterans Aging Cohort Study Index is an effective tool to assess baseline frailty status in a contemporary cohort of HIV-infected persons, AIDS Res Hum Retroviruses, vol.31, issue.3, pp.313-320, 2015.

J. A. Womack, J. L. Goulet, C. Gibert, C. A. Brandt, M. Skanderson et al., Physiologic frailty and fragility fracture in HIV-infected male veterans, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.56, issue.10, pp.1498-504, 2013.

T. D. Brothers, S. Kirkland, G. Guaraldi, J. Falutz, O. Theou et al., Frailty in people aging with human immunodeficiency virus (HIV) infection, J Infect Dis, vol.210, issue.8, pp.1170-1179, 2014.

S. G. Kelly, K. Wu, K. Tassiopoulos, K. M. Erlandson, S. L. Koletar et al., Frailty is an independent risk factor for mortality, cardiovascular disease, bone disease and diabetes among aging adults with HIV, Clin Infect Dis Off Publ Infect Dis Soc Am, 2018.

P. W. Hunt, J. N. Martin, E. Sinclair, B. Bredt, E. Hagos et al., , p.4

, T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy, J Infect Dis, vol.187, issue.10, pp.1534-1577, 2003.

J. Neuhaus, D. R. Jacobs, J. V. Baker, A. Calmy, D. Duprez et al., Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection, J Infect Dis, vol.201, issue.12, pp.1788-95, 2010.

L. H. Kuller, R. Tracy, W. Belloso, D. Wit, S. Drummond et al., Inflammatory and coagulation biomarkers and mortality in patients with HIV infection, PLoS Med, vol.5, issue.10, p.203, 2008.

N. G. Sandler, H. Wand, A. Roque, M. Law, M. C. Nason et al., Plasma levels of soluble CD14 independently predict mortality in HIV infection, J Infect Dis, vol.203, issue.6, pp.780-90, 2011.

T. H. Burdo, J. Lo, S. Abbara, J. Wei, M. E. Delelys et al., Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients, J Infect Dis, vol.204, issue.8, pp.1227-1263, 2011.

S. Krishnan, E. Wilson, V. Sheikh, A. Rupert, D. Mendoza et al., Evidence for innate immune system activation in HIV type 1-infected elite controllers, J Infect Dis, vol.209, issue.6, pp.931-940, 2014.

P. W. Hunt, H. L. Cao, C. Muzoora, I. Ssewanyana, J. Bennett et al., Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy, AIDS Lond Engl, vol.25, issue.17, pp.2123-2154, 2011.

P. Duffau, A. Ozanne, F. Bonnet, L. E. Cazanave, C. Blanco et al., age-related comorbidities and mortality: association of activation, senescence and inflammation markers in HIV adults, AIDS, 2018.

P. Duffau, L. Wittkop, L. E. Le-marec, F. Cognet, C. Blanco et al., Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV-suppressed patients, AIDS Lond Engl, vol.29, issue.16, pp.2099-108, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01288887

J. M. Brenchley, D. A. Price, T. W. Schacker, T. E. Asher, G. Silvestri et al., Microbial translocation is a cause of systemic immune activation in chronic HIV infection, Nat Med, vol.12, issue.12, pp.1365-71, 2006.

L. Wittkop, J. Bitard, L. E. Neau, D. Bonnet, F. Mercie et al., Effect of cytomegalovirus-induced immune response, self antigen-induced immune response, and microbial translocation on chronic immune activation in successfully treated HIV type 1-infected patients: the ANRS CO3 Aquitaine Cohort, J Infect Dis, vol.207, issue.4, pp.622-629, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01101196

B. Grund, J. V. Baker, S. G. Deeks, J. Wolfson, D. Wentworth et al., Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy, PloS One, vol.11, issue.5, p.155100, 2016.

N. T. Funderburg, E. Mayne, S. F. Sieg, R. Asaad, W. Jiang et al., Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation, Blood, vol.115, issue.2, pp.161-168, 2010.

A. D. Nordell, M. Mckenna, Á. H. Borges, D. Duprez, J. Neuhaus et al., Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation, J Am Heart Assoc, vol.3, issue.3, p.844, 2014.

J. N. Dock and R. B. Effros, Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence, Aging Dis, vol.2, issue.5, pp.382-97, 2011.

R. Ostan, L. Bucci, M. Capri, S. Salvioli, M. Scurti et al., Immunosenescence and immunogenetics of human longevity, Neuroimmunomodulation, vol.15, pp.224-264, 2008.

G. K. Robbins, J. G. Spritzler, E. S. Chan, D. M. Asmuth, R. T. Gandhi et al., Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.48, issue.3, pp.350-61, 2009.

C. Mussini, P. Lorenzini, A. Cozzi-lepri, G. Lapadula, G. Marchetti et al., CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study, Lancet HIV, vol.2, issue.3, pp.98-106, 2015.

A. N. Phillips, J. Neaton, and J. D. Lundgren, The role of HIV in serious diseases other than AIDS, AIDS Lond Engl, vol.22, issue.18, pp.2409-2427, 2008.

W. M. El-sadr, J. D. Lundgren, J. D. Neaton, F. Gordin, and D. Abrams, CD4+ count-guided interruption of antiretroviral treatment, N Engl J Med, vol.355, issue.22, pp.2283-96, 2006.

D. O'mahony, O. 'sullivan, D. Byrne, S. O'connor, M. N. Ryan et al., STOPP/START criteria for potentially inappropriate prescribing in older people: version 2, Age Ageing, vol.44, issue.2, pp.213-221, 2015.

V. K. Seecheran, S. L. Giddings, and N. A. Seecheran, Acute coronary syndromes in patients with HIV. Coron Artery Dis, vol.28, pp.166-72, 2017.

M. Durand, O. Sheehy, J. Baril, J. Lelorier, and C. L. Tremblay, Association between HIV infection, antiretroviral therapy, and risk of acute myocardial infarction: a cohort and nested case-control study using Québec's public health insurance database, J Acquir Immune Defic Syndr, vol.57, issue.3, pp.245-53, 1999.

L. Ryom, J. D. Lundgren, W. El-sadr, P. Reiss, O. Kirk et al., Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study, Lancet HIV, vol.5, issue.6, pp.291-300, 2018.

F. M. Islam, J. Wu, J. Jansson, and D. P. Wilson, Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis, HIV Med, vol.13, issue.8, pp.453-68, 2012.

D. R. Drozd, M. M. Kitahata, K. N. Althoff, J. Zhang, S. J. Gange et al., Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population, J Acquir Immune Defic Syndr, vol.75, issue.5, pp.568-76, 1999.

D. B. Hanna, C. Ramaswamy, R. C. Kaplan, J. R. Kizer, K. Anastos et al., Cardiovascular Disease Mortality Among Persons With HIV in, vol.63, pp.1122-1131, 2001.

E. Losina, E. P. Hyle, E. D. Borre, B. P. Linas, P. E. Sax et al., Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.65, issue.8, pp.1266-71, 201715.

P. J. Anderson, J. Critchley, J. Chan, C. S. Cockram, Z. Lee et al., Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality, Int J Obes, vol.25, issue.12, pp.1782-1790, 2001.

A. A. Paula, M. C. Falcão, and A. G. Pacheco, Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects, AIDS Res Ther, vol.10, issue.1, p.32, 2013.

S. A. Riddler, E. Smit, S. R. Cole, R. Li, J. S. Chmiel et al., Impact of HIV infection and HAART on serum lipids in men, JAMA, vol.289, issue.22, pp.2978-82, 2003.

C. N. Vu, R. Ruiz-esponda, Y. E. Chang, E. Gillard, B. Pownall et al., Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients, Metabolism, vol.62, issue.7, pp.1014-1034, 2013.

A. Nguyen, A. Calmy, C. Delhumeau, I. Mercier, M. Cavassini et al., A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study), AIDS Lond Engl, vol.25, issue.12, pp.1481-1488, 2011.

S. Safrin and C. Grunfeld, Fat distribution and metabolic changes in patients with HIV infection, AIDS Lond Engl, 1999.

M. P. Dubé, L. Komarow, K. Mulligan, S. K. Grinspoon, R. A. Parker et al., Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384, J Acquir Immune Defic Syndr, vol.45, issue.5, pp.508-522, 1999.

V. Amorosa, M. Synnestvedt, R. Gross, H. Friedman, R. R. Macgregor et al., A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia, J Acquir Immune Defic Syndr, vol.39, issue.5, pp.557-61, 1999.

C. J. Lyon, R. E. Law, and W. A. Hsueh, Minireview: adiposity, inflammation, and atherogenesis, Endocrinology, 2003.

C. Grunfeld, D. Rimland, C. L. Gibert, W. G. Powderly, S. Sidney et al., Association of Upper Trunk and Visceral Adipose Tissue Volume With Insulin Resistance in Control and HIV-Infected Subjects in the FRAM Study

, J Acquir Immune Defic Syndr, vol.46, issue.3, pp.283-90, 1999.

A. J. Blashill, K. H. Mayer, H. M. Crane, C. Grasso, and S. A. Safren, Body mass index, immune status, and virological control in HIV-infected men who have sex with men, J Int Assoc Provid AIDS Care, vol.12, issue.5, pp.319-343, 2013.

J. R. Koethe, C. A. Jenkins, B. E. Shepherd, S. E. Stinnette, and T. R. Sterling, An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.53, issue.9, pp.952-60, 2011.

B. Yuh, J. Tate, A. A. Butt, K. Crothers, M. Freiberg et al., Weight change after antiretroviral therapy and mortality, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.60, issue.12, pp.1852-1861, 2015.

K. Shah, T. N. Hilton, L. Myers, J. F. Pinto, A. E. Luque et al., A new frailty syndrome: central obesity and frailty in older adults with the human immunodeficiency virus, J Am Geriatr Soc, vol.60, issue.3, pp.545-554, 2012.

K. Samaras, H. Wand, M. Law, S. Emery, D. Cooper et al., Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia. Diabetes Care, vol.30, pp.113-122, 2007.

C. U. Nduka, S. Stranges, P. K. Kimani, A. M. Sarki, and O. A. Uthman, Is there sufficient evidence for a causal association between antiretroviral therapy and diabetes in HIV-infected patients? A meta-analysis, Diabetes Metab Res Rev, issue.6, p.33, 2017.

S. Dagogo-jack, HIV therapy and diabetes risk. Diabetes Care, vol.31, pp.1267-1275, 2008.

J. C. Smith, L. M. Evans, I. Wilkinson, J. Goodfellow, J. R. Cockcroft et al., Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebocontrolled study, Clin Endocrinol (Oxf), vol.56, issue.4, pp.493-501, 2002.

M. Hove-skovsgaard, J. C. Gaardbo, L. Kolte, K. Winding, I. Seljeflot et al., HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation, BMC Infect Dis, 2017.

C. Cazanave, M. Dupon, V. Lavignolle-aurillac, N. Barthe, S. Lawson-ayayi et al., Reduced bone mineral density in HIV-infected patients: prevalence and associated factors, AIDS Lond Engl, vol.22, issue.3, pp.395-402, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00186715

A. Fausto, M. Bongiovanni, P. Cicconi, L. Menicagli, E. V. Ligabò et al., Potential predictive factors of osteoporosis in HIV-positive subjects, Bone, vol.38, issue.6, pp.893-900, 2006.

M. O. Premaor and J. E. Compston, The Hidden Burden of Fractures in People Living With HIV, JBMR Plus, 2018.

L. Battalora, K. Buchacz, C. Armon, E. T. Overton, J. Hammer et al., Low bone mineral density and risk of incident fracture in HIV-infected adults, Antivir Ther, vol.21, issue.1, pp.45-54, 2016.

Á. H. Borges, J. Hoy, E. Florence, D. Sedlacek, H. Stellbrink et al., Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort, vol.64, pp.1413-1434, 2017.

T. T. Brown, C. Moser, J. S. Currier, H. J. Ribaudo, J. Rothenberg et al., Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir, J Infect Dis, vol.212, issue.8, pp.1241-1250, 2015.

L. Assoumou, C. Katlama, J. Viard, M. Bentata, A. Simon et al., Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia, AIDS Lond Engl, 2013.

M. Vandenhende, C. Roussillon, S. Henard, P. Morlat, E. Oksenhendler et al., Cancer-Related Causes of Death among HIV-Infected Patients in France in 2010: Evolution since, PloS One, vol.10, issue.6, p.129550, 2000.
URL : https://hal.archives-ouvertes.fr/hal-01289134

. Monforte-a-d'arminio, D. Abrams, C. Pradier, R. Weber, P. Reiss et al., HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies, AIDS Lond Engl, vol.22, issue.16, pp.2143-53, 2008.

E. A. Engels, E. L. Yanik, W. Wheeler, M. J. Gill, M. S. Shiels et al., Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.65, issue.4, pp.636-679, 2017.

A. Burgi, S. Brodine, S. Wegner, M. Milazzo, M. R. Wallace et al., Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals, Cancer, vol.104, issue.7, pp.1505-1516, 2005.

A. E. Grulich, M. T. Van-leeuwen, M. O. Falster, and C. M. Vajdic, Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis, Lancet Lond Engl, vol.370, issue.9581, pp.59-67, 2007.

R. K. Heaton, D. R. Franklin, R. J. Ellis, J. A. Mccutchan, S. L. Letendre et al., HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors, J Neurovirol, vol.17, issue.1, pp.3-16, 2011.

R. Saloner, R. K. Heaton, L. M. Campbell, A. Chen, D. Franklin et al., Effects of comorbidity burden and age on brain integrity in HIV, AIDS Lond Engl, vol.33, issue.7, pp.1175-85, 2019.

R. K. Heaton, D. R. Franklin, R. Deutsch, S. Letendre, R. J. Ellis et al., Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.60, issue.3, pp.473-80, 2015.

F. Bonnet, H. Amieva, F. Marquant, C. Bernard, M. Bruyand et al., Cognitive disorders in HIV-infected patients: are they HIV-related?, AIDS Lond Engl, vol.27, issue.3, pp.391-400, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01101101

T. Al-khindi, K. K. Zakzanis, and W. G. Van-gorp, Does antiretroviral therapy improve HIV-associated cognitive impairment? A quantitative review of the literature, J Int Neuropsychol Soc JINS, vol.17, issue.6, pp.956-69, 2011.

H. Oppenheim, E. W. Paolillo, R. C. Moore, R. J. Ellis, S. L. Letendre et al., Neurocognitive functioning predicts frailty index in HIV, Neurology, vol.91, issue.2, pp.162-70, 2018.

S. K. Mallipattu, F. Salem, and C. M. Wyatt, The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy, Kidney Int, vol.86, issue.2, pp.259-65, 2014.

M. Ando, K. Tsuchiya, and K. Nitta, How to manage HIV-infected patients with chronic kidney disease in the HAART era, Clin Exp Nephrol, vol.16, issue.3, pp.363-72, 2012.

P. Morlat, A. Vivot, M. Vandenhende, F. Dauchy, J. Asselineau et al., Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, vol.8, issue.6, p.66223, 2004.
URL : https://hal.archives-ouvertes.fr/hal-01101114

A. Ozanne, P. Duffau, F. Dauchy, C. Rigothier, C. Terrien et al., Activation, senescence and inflammation markers in HIV patients: association with renal function, AIDS Lond Engl, vol.31, issue.8, pp.1119-1147, 201715.

S. G. Deeks, S. R. Lewin, and D. V. Havlir, The End of AIDS: HIV Infection as a Chronic Disease, Lancet, vol.382, issue.9903, pp.1525-1558, 2013.